John Romans

President & CEO, BioMedix Vascular Solutions, Inc.

John RomansIn 1999, John Romans joined BioMedix Vascular Solutions, Inc., a small, start-up company based in St. Paul, Minnesota that focuses on the early detection of Peripheral Arterial Disease. John’s long-standing pursuit of excellence dates back to his education at Williams College (1990) and Wharton Business School (1995). His strong ambition led him to be involved as a founding principal in several technology-based ventures, helping him to become an experienced entrepreneur, while building a track record of developing and implementing innovative business models in emerging telecom, energy and healthcare markets.

Today, BioMedix offers the only integrated suite of hardware, software and online services to cost-effectively diagnose and manage patients with Peripheral Vascular Disease by enabling true collaboration between primary care physicians, podiatrists and vascular specialists. This provides the best guidance for diagnosing, treating and managing patients with this deadly disease, which affects 10 million Americans, before it can lead to serious consequences.

John Romans has furthered his goal of improving healthcare by partnering with various philanthropic organizations. In 2004, John led BioMedix to become a founding sponsor of the national P.A.D. Coalition and a sponsoring partner of the American Podiatric Medical Association (APMA). John serves as a board member of the Dare to C.A.R.E. Foundation and was recently awarded the APMA Executive Directors Award in recognition of the high level of support he has dedicated to the advancement of Podiatric medicine. Early in 2010, John Romans was invited by California Governor Arnold Schwarzenegger to participate in the California P.A.D. Task Force. John was named the 2010 Ernst and Young Entrepreneur of the Year in the Upper Midwest Region Technology Sector for demonstrating extraordinary success in the areas of innovation, financial performance and personal commitment to his business and community.

“There are millions of people with undiagnosed PAD,” Romans says. “That’s frustrating for the health care community because if properly diagnosed and treated, this disease can be managed with ease. But if left untreated, it can cause major quality-of-life compromises and be life-threatening. It doesn’t get any better than hearing that someone’s life was saved or that a grandparent was able to go shopping with their grandchild for the first time.”